Anaesthesic considerations with the use of GLIOLAN® for the resection of malicious gliomas
DOI:
https://doi.org/10.30445/rear.v10i7.610Keywords:
tumours, neurosurgery, Anaesthesia, GATIV, Gliolan, GliomasAbstract
High grade brain gliomas are among the most difficult infiltrate tumours for treatment and its surgical resection usually is not completed. The use of fluorescent markers (aminolevulinic acid hydrochloride (5 ALA) (Gliolan®) allows a more comprehensive removal of the injury.
References
1. http://www.ema.europa.eu/docs/es_ES/document_library/EPAR_-_Product_Information/human/000744/WC500021790
2. Carretero, M; Negrete, N; Muñoz, G; Sánchez, J; Bernal, LM. Anesthetic treatment during resection of high-grade malignant gliomas after injection of 5-aminolevulinic acid to enhance intraoperative visualization. Rev Esp Anestesiol Reanim, 2010 vol. 57(6) pp. 393-5.
3. Fernández-Candil, J; Pacreu, S; Villaba, G; Fernández, GS. Anesthetic approach and implications of the use of 5-aminolevulinic acid as a tumor marker in the resection of malignant gliomas. Rev Esp Anestesiol Reanim, 2010 vol. 57(6) pp. 395-6.
4. Buijs. EJ, Scholten JG, Ross JJ. Successful administration of sugammadex in a patient with acute porphyria: A case report. Eur J Anasthesiol. 2014 Aug (8) 439-441.
2. Carretero, M; Negrete, N; Muñoz, G; Sánchez, J; Bernal, LM. Anesthetic treatment during resection of high-grade malignant gliomas after injection of 5-aminolevulinic acid to enhance intraoperative visualization. Rev Esp Anestesiol Reanim, 2010 vol. 57(6) pp. 393-5.
3. Fernández-Candil, J; Pacreu, S; Villaba, G; Fernández, GS. Anesthetic approach and implications of the use of 5-aminolevulinic acid as a tumor marker in the resection of malignant gliomas. Rev Esp Anestesiol Reanim, 2010 vol. 57(6) pp. 395-6.
4. Buijs. EJ, Scholten JG, Ross JJ. Successful administration of sugammadex in a patient with acute porphyria: A case report. Eur J Anasthesiol. 2014 Aug (8) 439-441.
Downloads
Published
2020-09-10
How to Cite
Benito Naverac, H. (2020). Anaesthesic considerations with the use of GLIOLAN® for the resection of malicious gliomas. Revista Electrónica AnestesiaR, 10(7), 3. https://doi.org/10.30445/rear.v10i7.610
Issue
Section
Review articles
License
Copyright (c) 2018 Revista Electrónica AnestesiaR
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
Envío y derechos de autor
Revista Electrónica AnestesiaR by 